Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling

Gina L. Zoratti(The Barbara Ann Karmanos Cancer Institute), Karin List(National Institute of Dental and Craniofacial Research)
Nature Communications
April 15, 2015
Cited by 63


Related Papers